Fasenra: An Asthma Study

NCT07654842 · clinicaltrials.gov ↗

PHASE4

Phase

ENROLLING_BY_INVITATION

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Eosinophilic Asthma
Severe Asthma
Severe Eosinophilic Asthma
Asthma

Interventions

DRUG: Budesonide-albuterol
DRUG: Benralizumab

Sponsor

Endeavor Health

Collaborators

[object Object]